As the GLP-1 category evolves, many providers are seeking flexible, clinically sound alternatives to support their patients’ weight loss journeys, particularly when long-term sustainability and access to supply are considerations.

That’s why WeCare Pharmacy is now offering Liraglutide, a compounded daily-dose GLP-1 therapy.

Liraglutide works by mimicking the body’s natural GLP-1 hormone, which helps regulate appetite, improve glycemic control, and promote weight loss. While it’s not new to the field, it’s gaining renewed attention as a reliable, daily option for both ongoing treatment and microdosing strategies.

This option may be ideal for:

• Patients transitioning from weekly injections to daily maintenance
• Clinics navigating regulatory uncertainties around semaglutide and tirzepatide
• Providers seeking dose flexibility with known GLP-1 efficacy

At a time when some compounders are pulling back, WeCare is committed to keeping more weight loss options on the table.

We compound Liraglutide in a form that offers precise dosing control, supported by our expert pharmacists and nationwide delivery model.

Log in to the WeCare Provider Portal or contact your rep to get started.